Evidence map›Paper›PMID 32381591›Full record

ArticleScience (New York, N.Y.)2020

Supramolecular attack particles are autonomous killing entities released from cytotoxic T cells.

Š Bálint, S Müller, R Fischer, B M Kessler, M Harkiolaki, S Valitutti, M L Dustin

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 170 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. The roles and heterogeneity of CD8International journal of molecular medicine · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Activation-induced thrombospondin-4 works with thrombospondin-1 to build cytotoxic supramolecular attack particles.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  20. Harnessing extracellular vesicle-mediated crosstalk between T cells and cancer cells for therapeutic applications.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Review

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Š BálintKennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.ORCID 0000-0003-4470-5881
S MüllerCancer Research Center of Toulouse, INSERM, Toulouse, France.ORCID 0000-0002-4580-2758
R FischerDiscovery Proteomics Facility, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-9715-5951
B M KesslerDiscovery Proteomics Facility, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-8160-2446
M HarkiolakiDiamond Light Source, Harwell Science and Innovation Campus, Chilton, Didcot, UK.ORCID 0000-0001-8091-9057
S ValituttiCancer Research Center of Toulouse, INSERM, Toulouse, France.ORCID 0000-0002-6432-4421
M L DustinKennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. michael.dustin@kennedy.ox.ac.uk.ORCID 0000-0003-4983-6389
Inserm · FRNuffield Orthopaedic Centre · GBUniversity of Oxford · GBDiamond Light Source · GB

Funding

European Research Council 670930Wellcome Trust 100262
6 · The paper itself

Abstract

Cytotoxic T lymphocytes (CTLs) kill infected and cancerous cells. We detected transfer of cytotoxic multiprotein complexes, called supramolecular attack particles (SMAPs), from CTLs to target cells. SMAPs were rapidly released from CTLs and were autonomously cytotoxic. Mass spectrometry, immunochemical analysis, and CRISPR editing identified a carboxyl-terminal fragment of thrombospondin-1 as an unexpected SMAP component that contributed to target killing. Direct stochastic optical reconstruction microscopy resolved a cytotoxic core surrounded by a thrombospondin-1 shell of ~120 nanometer diameter. Cryo-soft x-ray tomography analysis revealed that SMAPs had a carbon-dense shell and were stored in multicore granules. We propose that SMAPs are autonomous extracellular killing entities that deliver cytotoxic cargo targeted by the specificity of shell components.

Indexed as

Cytotoxicity, ImmunologicCRISPR-Cas SystemsExocytosisGene EditingGranzymesHumansK562 CellsMultiprotein ComplexesPerforinThrombospondin 1T-Lymphocytes, CytotoxicTomography, X-RayGranzymesMultiprotein ComplexesPerforinThrombospondin 1

Identifiers

PMID32381591
PMCPMC7116847
OpenAlexW3023651157

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.